A microED pipeline for the pharmaceutical and biotechnology industry
适用于制药和生物技术行业的 microED 管道
基本信息
- 批准号:10402253
- 负责人:
- 金额:$ 68.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAcetaminophenAddressAlgorithmsAutomationBiological ProductsBiotechnologyBiotinClientClinicCollectionCommercial SectorsComplexComputer softwareCrystallizationDataData CollectionData SetDevelopmentDrug CostsDrug DesignElectron MicroscopeEnsureEventFeedbackGoalsHandednessHealthHourHumanImageIndustrializationIndustryKnowledgeMapsMethodsMicro Electron DiffractionMicroscopeModelingMolecularMolecular TargetNatural ProductsOnline SystemsPeptidesPharmaceutical ChemistryPharmaceutical PreparationsPharmacologic SubstancePhasePreparationProceduresProcessProgesteronePropertyProteinsReproducibilityResearchResolutionRobotRotationSamplingSeriesServicesSpecificitySpecimenSpeedStructureSystemTechniquesTestingTimeWorkX-Ray Crystallographybasechemotherapychiral moleculecomputerized data processingcostcrystallinitydata acquisitiondata analysis pipelinedata qualitydata reductiondrug developmentdrug discoveryelectron diffractionflexibilityimprovedimproved outcomeinterestmicroscopic imagingnanoimagingnovelnovel strategiesprogramsscreeningsmall moleculestatisticstargeted treatmentthree dimensional structuretransmission process
项目摘要
Project Summary/Abstract
Microcrystal electron diffraction (microED) is an emerging structure determination technique of high interest to
the pharmaceutical and biotechnology industries. MicroED can rapidly determine atomic-resolution structures
from microcrystals with minimal sample requirements. The goal of this Phase II proposal is to develop and deliver
robust service offerings for microED structure determination to the commercial sector. Improvements to critical
steps in this workflow will enable analysis for any suitable sample type while offering a level of efficiency that
meets the requirements of Structure-Based Drug Design (SBDD) and medicinal chemistry programs. The
permissive sample requirements, minimal time requirements, and high-quality structures generated make
microED an attractive structure determination technique with broad applications for small molecules, peptides,
natural products, proteins and protein-drug complexes. An efficient microED pipeline will help to reduce the cost
of drug development and reduce the time it takes a drug to make it into the clinic.
MicroED uses a transmission electron microscope (TEM) to collect diffraction data from small crystalline
samples. The steps required include transferring crystalline samples to TEM grids; collecting a series of
continuous-rotation, electron-diffraction datasets from single crystals; processing the diffraction data and refining
the atomic model. An initial development phase demonstrated collection of excellent quality diffraction datasets
for more than 20 samples, and the ability to deliver atomic resolution maps suitable for addressing the needs of
our pharmaceutical clients who took part in alpha and beta testing. New methods will be developed, and existing
approaches optimized to improve every step of this pipeline, substantially increase throughput, and improve final
maps and models. Specific aims include: (1) Optimizing TEM grid preparation to ensure the transfer of a sufficient
number of high-quality target microcrystals onto the grid substrate without damaging them or altering their
properties. (2) Developing an automated, high-throughput data collection system capable of unattended,
overnight data acquisition for multiple different samples, and of providing information to inform data scaling and
determining handedness of chiral small molecules. (3) Automating and improving data processing, phasing and
model refinement including real-time data reduction, brute force on-the-fly phasing, and investigating a wide
range of new programs and methods.
In parallel with the Phase II research plan, a full commercial service offering spanning the complete range of
microED capabilities will be developed.
项目概要/摘要
微晶电子衍射 (microED) 是一种新兴的结构测定技术,引起了人们的极大兴趣
制药和生物技术行业。 MicroED 可以快速确定原子分辨率的结构
从微晶中提取,样品要求极低。第二阶段提案的目标是开发和交付
为商业领域的 microED 结构测定提供强大的服务。关键改进
此工作流程中的步骤将能够对任何合适的样品类型进行分析,同时提供一定程度的效率
满足基于结构的药物设计(SBDD)和药物化学项目的要求。这
宽松的样品要求、最短的时间要求以及生成的高质量结构使得
microED 是一种有吸引力的结构测定技术,在小分子、肽、
天然产物、蛋白质和蛋白质药物复合物。高效的 microED 管道将有助于降低成本
药物开发并减少药物进入临床所需的时间。
MicroED 使用透射电子显微镜 (TEM) 收集小晶体的衍射数据
样品。所需步骤包括将晶体样品转移至 TEM 网格;收集一系列的
来自单晶的连续旋转、电子衍射数据集;处理衍射数据并精炼
原子模型。初始开发阶段展示了高质量衍射数据集的收集
适用于 20 多个样品,并且能够提供适合满足以下需求的原子分辨率图
我们参与 alpha 和 beta 测试的制药客户。将开发新方法,并利用现有方法
优化方法以改进该管道的每一步,大幅提高吞吐量并改善最终结果
地图和模型。具体目标包括: (1) 优化 TEM 网格制备以确保足够的转移
将大量高质量目标微晶沉积到网格基板上,而不会损坏它们或改变它们
特性。 (2) 开发自动化、高通量的数据采集系统,能够实现无人值守、
过夜获取多个不同样本的数据,并提供信息以告知数据缩放和
确定手性小分子的旋手性。 (3) 自动化和改进数据处理、分阶段和
模型细化,包括实时数据缩减、强力动态定相以及广泛的调查
一系列新的计划和方法。
与第二阶段研究计划并行,涵盖整个范围的全面商业服务
将开发 microED 功能。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Absolute configuration determination of pharmaceutical crystalline powders by MicroED via chiral salt formation.
通过 MicroED 通过手性盐形成确定药物结晶粉末的绝对构型。
- DOI:
- 发表时间:2022-04-12
- 期刊:
- 影响因子:0
- 作者:Wang, Bo;Bruhn, Jessica F;Weldeab, Asmerom;Wilson, Timothy S;McGilvray, Philip T;Mashore, Michael;Song, Qiong;Scapin, Giovanna;Lin, Yiqing
- 通讯作者:Lin, Yiqing
Absolute Configuration Determination of Chiral API Molecules by MicroED Analysis of Cocrystal Powders Formed Based on Cocrystal Propensity Prediction Calculations.
通过基于共晶倾向预测计算形成的共晶粉末的 MicroED 分析来确定手性 API 分子的绝对构型。
- DOI:
- 发表时间:2023-03-07
- 期刊:
- 影响因子:0
- 作者:Shah, Harsh S;Yuan, Jiuchuang;Xie, Tian;Yang, Zhuocen;Chang, Chao;Greenwell, Chandler;Zeng, Qun;Sun, GuangXu;Read, Brandon N;Wilson, Timothy S;Valle, Henry U;Kuang, Shanming;Wang, Jian;Sekharan, Sivakumar;Bruhn, Jessica F
- 通讯作者:Bruhn, Jessica F
Small Molecule Microcrystal Electron Diffraction for the Pharmaceutical Industry-Lessons Learned From Examining Over Fifty Samples.
用于制药行业的小分子微晶电子衍射 - 从检查五十多个样品中吸取的经验教训。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Bruhn, Jessica F;Scapin, Giovanna;Cheng, Anchi;Mercado, Brandon Q;Waterman, David G;Ganesh, Thejusvi;Dallakyan, Sargis;Read, Brandon N;Nieusma, Travis;Lucier, Kyle W;Mayer, Megan L;Chiang, Nicole J;Poweleit, Nicole;McGilvray, Philip T;Wilson
- 通讯作者:Wilson
From Powders to Single Crystals: A Crystallographer's Toolbox for Small-Molecule Structure Determination.
从粉末到单晶:用于小分子结构测定的晶体学家工具箱。
- DOI:
- 发表时间:2022-07-04
- 期刊:
- 影响因子:4.9
- 作者:Newman, Justin A;Iuzzolino, Luca;Tan, Melissa;Orth, Peter;Bruhn, Jessica;Lee, Alfred Y
- 通讯作者:Lee, Alfred Y
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Fox Bruhn其他文献
Jessica Fox Bruhn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
CHAC1通过调控蛋白谷胱甘肽化修饰促进对乙酰氨基酚诱导急性药物性肝损伤的作用和机制研究
- 批准号:82370597
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
金银花中绿原酸类化合物通过激活Keap1/Nrf2-PPARα通路促进对乙酰氨基酚肝损伤后肝脏再生修复的研究
- 批准号:82304845
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
IER2通过Hippo信号通路保护对乙酰氨基酚诱导的肝损伤
- 批准号:82373967
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于超小MOF-818构筑的纳米酶复合物催化前药对乙酰氨基酚的氧化及其抗肿瘤机制
- 批准号:32371463
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ENDOG促进对乙酰氨基酚引起肝损伤的作用及机制研究
- 批准号:82370596
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 68.37万 - 项目类别:
Assessing fentanyl test strip use accuracy and fentanyl presence in the non-heroin drug supply
评估芬太尼试纸的使用准确性和非海洛因毒品供应中芬太尼的存在
- 批准号:
10668083 - 财政年份:2023
- 资助金额:
$ 68.37万 - 项目类别:
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury
EGFR 和 MET 在对乙酰氨基酚诱导的急性肝损伤中的不同作用
- 批准号:
10633557 - 财政年份:2023
- 资助金额:
$ 68.37万 - 项目类别:
Neurodevelopmental Effect of Acetaminophen Exposures
对乙酰氨基酚暴露对神经发育的影响
- 批准号:
10736409 - 财政年份:2023
- 资助金额:
$ 68.37万 - 项目类别:
A synergistic in vitro-in silico model of the placental barrier for predicting fetal exposure and toxicity of xenobiotic compounds
胎盘屏障的协同体外计算机模拟模型,用于预测胎儿的外源化合物暴露和毒性
- 批准号:
10698740 - 财政年份:2023
- 资助金额:
$ 68.37万 - 项目类别: